The present invention relates to compds. of formula (I) (I) or pharmaceutically acceptable
salts, and stereoisomers thereof, including enantiomers, racemic mixts., mixts. of
enantiomers, or combinations thereof, which are applicable for use in treating cancer
diseases. The present invention further relates to a pharmaceutical compn. comprising
the above compds. [on SciFinder(R)]